What is the price target for ALQGC stock?
7 analysts have analysed ALQGC.PA and the average price target is 10.2 EUR. This implies a price increase of 14047.02% is expected in the next year compared to the current price of 0.0721.
QUANTUM GENOMICS SAS-REGR (ALQGC.PA) Forecast, Price Target & Analyst Ratings
EPA:ALQGC • FR0011648971
Current stock price
0.0721 EUR
0 (-1.77%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for QUANTUM GENOMICS SAS-REGR (ALQGC.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€10.20
Upside
+ 14,047.02%
From current price of €0.07 to mean target of €10.20, Based on 7 analyst forecasts
Low
€10.10
Median
€10.20
High
€10.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for ALQGC.PA. The average price target is 10.2 EUR. This implies a price increase of 14047.02% is expected in the next year compared to the current price of 0.0721.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
34.29%
ALQGC.PA was analyzed by 7 analysts. The buy percentage consensus is at 34. So analysts seem to be rather negative about ALQGC.PA.
In the previous month the buy percentage consensus was at a similar level.
ALQGC.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 116.21K -90.34% | 604.98K 420.59% | 10.06K -98.34% | 138.69M 1,378,528.23% | |
| EBITDA YoY % growth | -18.901M -38.09% | N/A 35.13% | N/A 53.80% | 70.813M 1,350.01% | |
| EBIT YoY % growth | -19.187M -38.46% | -30.083M -56.79% | -3.137M 89.57% | 70.607M 2,350.60% | |
| Operating Margin | -16,510.65% | -4,972.59% | -31,185.39% | 50.91% | |
| EPS YoY % growth | N/A -200.63% | N/A 22.11% | N/A 81.08% | 4.34 6,121.43% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
QUANTUM GENOMICS SAS-REGR / ALQGC.PA Forecast FAQ
How many analysts cover QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock?
The number of analysts covering QUANTUM GENOMICS SAS-REGR (ALQGC.PA) is 7.